Literature DB >> 10706466

Primary bilateral adrenal lymphoma associated with idiopathic thrombocytopenic purpura.

E Yamamoto1, N Ozaki, M Nakagawa, M Kimoto.   

Abstract

Autoimmune disorders are occasionally associated with malignant lymphoma. To date only one case of primary adrenal lymphoma associated with idiopathic thrombocytopenic purpura (ITP) has ever been reported. This paper reports the case of a 63-year-old man with bilateral adrenal masses whose laboratory data showed decreased platelet count. Despite normal blood pressure, the adrenal tumors endocrinologically appeared to be pheochromocytoma. Core needle biopsy was not done due to thrombocytopenia attributed to concurrent ITP. After intravenous immunoglobulin treatment, splenectomy and bilateral adrenalectomy were performed since the first pathological findings of the frozen specimen suggested the possibility of a poorly-differentiated carcinoma. Immunohistochemical study finally showed the tumors to be diffuse large B-cell lymphoma. The patient underwent a subsequent course of combination chemotherapy and survived 6 years recurrence-free without any need for further treatment other than steroid replacement. The coincidence of adrenal lymphoma and ITP should be considered even if another kind of tumor is suspected, and core needle biopsy should be performed prior to operation, since the specific kind of tumor found alters the therapeutical strategy adopted.

Entities:  

Mesh:

Year:  1999        PMID: 10706466     DOI: 10.3109/10428199909145746

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  5 in total

1.  Synchronous Occurrence of Diffuse Large B-cell Lymphoma of the Duodenum and Gastrointestinal Stromal Tumor of the Ileum in a Patient with Immune Thrombocytopenic Purpura.

Authors:  Tohru Takahashi; Yumiko Maruyama; Mayuko Saitoh; Hideto Itoh; Mitsuru Yoshimoto; Masayuki Tsujisaki; Masato Nakayama
Journal:  Intern Med       Date:  2016-10-15       Impact factor: 1.271

2.  A case of primary adrenal diffuse large B-cell lymphoma achieving complete remission with rituximab-CHOP chemotherapy.

Authors:  Kyung Min Kim; Dok Hyun Yoon; Seung Geun Lee; Sung Nam Lim; Lyu Jin Sug; Jooryung Huh; Cheolwon Suh
Journal:  J Korean Med Sci       Date:  2009-06-16       Impact factor: 2.153

3.  Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL).

Authors:  Yu Ri Kim; Jin Seok Kim; Yoo Hong Min; Dok Hyunyoon; Ho-Jin Shin; Yeung-Chul Mun; Yong Park; Young Rok Do; Seong Hyun Jeong; Joon Seong Park; Sung Yong Oh; Suee Lee; Eun Kyung Park; Joung-Soon Jang; Won-Sik Lee; Hwe-Won Lee; Hyeonseok Eom; Jae-Sook Ahn; Jae-Heon Jeong; Sun Kyung Baek; Seok Jin Kim; Won Seog Kim; Cheolwon Suh
Journal:  J Hematol Oncol       Date:  2012-08-13       Impact factor: 17.388

4.  Primary extra-nodal diffuse large B-cell lymphoma: A prognostic analysis of 141 patients.

Authors:  Haorui Shen; Zhang Wei; Daobin Zhou; Yan Zhang; Xiao Han; Wei Wang; Lu Zhang; Chen Yang; Jun Feng
Journal:  Oncol Lett       Date:  2018-05-24       Impact factor: 2.967

5.  Successful Treatment of Aggressive Mature B-cell Lymphoma Mimicking Immune Thrombocytopenic Purpura.

Authors:  Koya Ono; Yasushi Onishi; Masahiro Kobayashi; Satoshi Ichikawa; Shunsuke Hatta; Shotaro Watanabe; Yoko Okitsu; Noriko Fukuhara; Ryo Ichinohasama; Hideo Harigae
Journal:  Intern Med       Date:  2018-03-30       Impact factor: 1.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.